Literature DB >> 17202941

Supracricoid laryngectomy outcomes: The Johns Hopkins experience.

Tarik Y Farrag1, Wayne M Koch, Charles W Cummings, David Goldenberg, Peter M Abou-Jaoude, Joseph A Califano, Paul W Flint, Kimberly Webster, Ralph P Tufano.   

Abstract

OBJECTIVE: To report the oncologic and functional results from our experience in performing supracricoid laryngectomy (SCL) for selected patients with laryngeal cancer. STUDY
DESIGN: Retrospective chart review.
METHODS: Twenty-four consecutive patients who underwent SCL for laryngeal cancer in our institution from December 2000 to March 2006 have been reviewed. Reports of the site and extent of tumor, type of reconstruction, preoperative or postoperative radiotherapy, and the final histopathologic examination were reviewed. In addition, the reports of the preoperative examination, inpatient course, and postoperative follow-up were reviewed.
RESULTS: A total of 24 patients were involved in the study; 19 had tumors involving the glottic region, and 5 patients had tumors involving both the glottic and supraglottic regions (transglottic). Ten patients had their SCL for postradiotherapy recurrence/persistence of disease. Eighteen patients underwent reconstruction through cricohyoidoepiglottopexy (CHEP), whereas six patients had cricohyoidopexy (CHP). Eleven patients had an arytenoid cartilage resected; 8 of 11 had CHEP, and 3 of 11 had CHP. All patients had a tracheostomy and percutaneous endoscopic gastrostomy (PEG) tube placement performed at the same time as the SCL. The median hospital stay period was 6 days. Twenty-three of 24 had successful tracheostomy tube decannulation, with a median time to decannulation of 37 days. The median time to removal of the PEG tube was 70 days. The complications with SCL were postoperative wound infection in two patients (SCL/CHP) and the need for completion total laryngectomy secondary to intractable aspiration in one patient with SCL/CHP. One patient with SCL/CHEP had a ruptured pexy and subsequently underwent a second reconstruction with successful tracheostomy and PEG tube removal. One of 24 patients is still PEG tube dependant, and he had postoperative radiotherapy. Fifteen patients underwent concurrent neck dissection. None of the patients had any local or regional recurrence, with a median follow-up period of 3 years. All final surgical margins were negative for tumor invasion. Three patients had postoperative radiotherapy, two patients because of nodal metastases in the excised lymph nodes and one because of perineural invasion on final histopathologic examination of the SCL specimen. There were no perioperative deaths.
CONCLUSION: SCL with CHEP or CHP represents an effective technique that can be taught and effectively used to avoid a total laryngectomy while maintaining physiologic speech and swallowing in selected patients with advanced stage primary laryngeal cancer or recurrent/persistent laryngeal cancer after radiotherapy. There is a good functional recovery with acceptable morbidity and an excellent oncologic outcome when strict selection criteria are applied and a formal swallowing rehabilitation program is followed.

Entities:  

Mesh:

Year:  2007        PMID: 17202941     DOI: 10.1097/01.mlg.0000247660.47625.02

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  14 in total

Review 1.  Functional outcomes after supracricoid laryngectomy: what do we not know and what do we need to know?

Authors:  Antonio Schindler; Nicole Pizzorni; Francesco Mozzanica; Marco Fantini; Daniela Ginocchio; Andy Bertolin; Erika Crosetti; Giovanni Succo
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-11-06       Impact factor: 2.503

2.  Asymmetric mineralization of the arytenoid cartilages in patients without laryngeal cancer.

Authors:  E Zan; D M Yousem; N Aygun
Journal:  AJNR Am J Neuroradiol       Date:  2011-04-14       Impact factor: 3.825

3.  Outcome of conservation surgery for laryngeal carcinoma: an 8-year trial.

Authors:  Bilge Tuna; Hüseyin Katilmiş; Sedat Oztürkcan; Ali Ekber Ilknur; Riza Dündar; Yimaz Ozkul; Sinem Aktaş; Filiz Gülistan
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11       Impact factor: 2.503

4.  Transoral robotic supracricoid partial laryngectomy with cartilaginous framework preservation.

Authors:  Emre Vural; Ozlem E Tulunay-Ugur; James Y Suen
Journal:  J Robot Surg       Date:  2012-04-04

5.  Expression of Th1- Th2- and Th17-associated cytokines in laryngeal carcinoma.

Authors:  Xiaoqun Xu; Rui Wang; Qinghong Su; Haiyan Huang; Peng Zhou; Junwen Luan; Jingsheng Liu; Junfu Wang; Xuemei Chen
Journal:  Oncol Lett       Date:  2016-07-13       Impact factor: 2.967

Review 6.  Conservative treatment for advanced T3-T4 laryngeal cancer: meta-analysis of key oncological outcomes.

Authors:  Giuditta Mannelli; Maria Silvia Lazio; Paolo Luparello; Oreste Gallo
Journal:  Eur Arch Otorhinolaryngol       Date:  2017-11-08       Impact factor: 2.503

7.  Supracricoid laryngectomy with cricohyoidopexy: oncological results.

Authors:  Ilhan Topaloğlu; Muhlis Bal; Ziya Salturk
Journal:  Eur Arch Otorhinolaryngol       Date:  2011-12-01       Impact factor: 2.503

Review 8.  Current trends in initial management of laryngeal cancer: the declining use of open surgery.

Authors:  Carl E Silver; Jonathan J Beitler; Ashok R Shaha; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-07-14       Impact factor: 2.503

9.  Supracricoid laryngectomy with cricohyoidoepiglottopexy (CHEP) in the management of laryngeal carcinoma: oncologic results. A 35-year experience.

Authors:  C Page; G Mortuaire; F Mouawad; O Ganry; J Darras; X Pasquesoone; D Chevalier
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-12-04       Impact factor: 2.503

Review 10.  Organ preservation surgery for laryngeal cancer.

Authors:  Sharad Chawla; Andrew Simon Carney
Journal:  Head Neck Oncol       Date:  2009-05-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.